Ticker > Company >

Shilpa Medicare share price

Shilpa Medicare Ltd.

NSE: SHILPAMED BSE: 530549 SECTOR: Pharmaceuticals & Drugs  78.21 K   186   35

834.50
-0.35 (-0.04%)
BSE: 11 Sep 04:01 PM

Price Summary

Today's High

₹ 855

Today's Low

₹ 830

52 Week High

₹ 1003.2

52 Week Low

₹ 530.5

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

8160.65 Cr.

Enterprise Value

8300.07 Cr.

No. of Shares

9.78 Cr.

P/E

131.3

P/B

3

Face Value

₹ 1

Div. Yield

0.12 %

Book Value (TTM)

₹  278.28

CASH

3.13 Cr.

DEBT

142.55 Cr.

Promoter Holding

44.23 %

EPS (TTM)

₹  6.36

Sales Growth

25.06%

ROE

1.26 %

ROCE

2.36%

Profit Growth

154.44 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year25.06%
3 Year6.42%
5 Year-14.14%

Profit Growth

1 Year-52.9%
3 Year-47.33%
5 Year-26.33%

ROE%

1 Year1.26%
3 Year0%
5 Year3.3%

ROCE %

1 Year2.36%
3 Year0.79%
5 Year4.03%

Debt/Equity

0.0665

Price to Cash Flow

1015.8

Interest Cover Ratio

3.2072

CFO/PAT (5 Yr. Avg.)

1.66048637379028

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 44.23 7.92
Mar 2025 44.23 7.92
Dec 2024 44.23 7.92
Sep 2024 44.33 7.90
Jun 2024 44.39 90.41
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 144.8696 Cr.
  • Company is virtually debt free.
  • Company’s PEG ratio is 0.850165812507448.
  • The company has an efficient Cash Conversion Cycle of 77.7921 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.66048637379028.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 4.96846968619313.

 Limitations

  • The company has shown a poor profit growth of -25.4800278584316% for the Past 3 years.
  • The company has shown a poor revenue growth of 6.41784374112666% for the Past 3 years.
  • Company has a poor ROE of -0.00419547935880008% over the past 3 years.
  • Company has a poor ROCE of 0.786698899258323% over the past 3 years
  • Company has contingent liabilities of 655.2432 Cr.
  • The company is trading at a high PE of 131.3.
  • The company is trading at a high EV/EBITDA of 43.9942.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 96.12 129.68 125.39 126.15 92.43
Total Expenditure 72.76 86.83 102.82 90.92 75.43
Operating Profit 23.36 42.86 22.56 35.23 17
Other Income 31.4 21.47 16.83 14.08 17.79
Interest 1.77 1.19 1.38 2.09 2.23
Depreciation 12.3 12.02 12.2 12.34 12.59
Exceptional Items -0.46 -0.47 -0.49 -44.32 -5.18
Profit Before Tax 40.23 50.65 25.33 -9.43 14.78
Tax 12.34 20.16 9.21 -4.28 -5.91
Profit After Tax 27.88 30.49 16.12 -5.15 20.7
Adjusted EPS (Rs) 2.85 3.12 1.65 -0.53 2.12

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 805.97 257.05 356.95 247.7 309.79
Total Expenditure 568.18 228.58 345.93 302.88 287.72
Operating Profit 237.79 28.47 11.02 -55.17 22.07
Other Income 18.37 37.14 51.52 79.82 93.34
Interest 4.33 6.07 9.05 20.83 17.26
Depreciation 34.96 22.28 34.82 46.55 49.61
Exceptional Items -4.54 52.95 8.81 -15.55 -10.45
Profit Before Tax 212.34 90.21 27.49 -58.28 38.09
Tax 44.15 25.12 7.33 -8.79 11.15
Net Profit 193.72 184.39 140.99 57.19 26.94
Adjusted EPS (Rs.) 20.63 7.98 2.32 -5.7 3.1

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 8.15 8.15 8.68 8.68 8.68
Total Reserves 1445.27 1629.68 2056.99 2108.9 2134.04
Borrowings 164.48 324.52 120.28 122.8 16.25
Other N/C liabilities 43.52 81.06 89.87 35.56 33.28
Current liabilities 359.86 473.98 161.65 242.71 226.34
Total Liabilities 2021.28 2517.39 2896.12 2518.66 2418.58
Assets
Net Block 517 640.9 565.78 608.93 586.33
Capital WIP 244.18 297.19 52.57 41.84 9.92
Intangible WIP 128.63 185.16 240.55 184.59 218.32
Investments 93.48 219.32 237.5 243.92 246.45
Loans & Advances 124.54 391.84 595.14 802.92 980.26
Other N/C Assets 5.76 3.1 895.15 0.2 0.38
Current Assets 907.69 779.9 309.44 636.25 376.93
Total Assets 2021.28 2517.39 2896.12 2518.66 2418.58
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 233.99 255.54 192.89 12.68 38.09
Adjustment -5.39 -25.46 32.64 -35.56 7.17
Changes in Assets & Liabilities -57.95 -117.1 -17.17 33.37 -30.28
Tax Paid -40.85 -43.34 -34.49 -8.41 -6.95
Operating Cash Flow 129.79 69.63 173.87 2.08 8.03
Investing Cash Flow -302.49 -238.13 -378.97 -94.83 155.82
Financing Cash Flow 170.1 255.58 97.23 87.68 -163.07
Net Cash Flow -2.59 87.08 -107.88 -5.07 0.78

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 44.39 44.33 44.23 44.23 44.23
brijgopal innani 1.20 1.20 1.20 1.20 1.20
deepak kumar innani 2.80 2.80 2.80 2.80 2.80
dharmavati bhutada 6.35 6.35 6.35 6.35 6.35
kamalkishore innani 0.17 0.17 0.17 0.17 0.17
kantadevi inani 2.60 2.60 2.60 2.60 2.60
keerti innani 0.16 0.16 0.16 0.16 0.16
keshav bhutada 2.05 2.05 2.05 2.05 2.05
madhav vishnukant bhutada... 2.05 2.05 2.05 2.05 2.05
manjulatha innani 0.16 0.16 0.16 0.16 0.16
namrata bhutada 0.02 0.02 0.02 0.02 0.02
natamal innani 1.16 1.16 1.16 1.16 1.16
om prakash inani 2.93 2.93 2.93 2.93 2.93
priya inani - 0.18 0.08 0.08 0.08
ramakant innani 1.53 1.53 1.53 1.53 1.53
ravi kumar innani 4.10 4.10 4.10 4.10 4.10
sagar innani 1.02 1.02 1.02 1.02 1.02
shakuntalabai innani 1.15 1.15 1.15 1.15 1.15
suraj kumar inani - 4.01 4.01 4.01 4.01
taradevi innani 1.28 1.28 1.28 1.28 1.28
triveni inani 0.30 0.30 0.30 0.30 0.30
vishnukant chaturbhuj bhu... 6.51 6.51 6.51 6.51 6.51
vishnukanta inani 1.24 1.24 1.24 1.24 1.24
vishnukanth c bhutada (hu... 1.37 1.37 1.37 1.37 1.37
priya innani 0.18 - - - -
suraj kumar innani 4.07 - - - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 55.61 55.67 55.77 55.77 55.77
akash bhanshali 1.64 1.55 1.55 1.52 1.52
amal parikh - - - - 1.73
bandhan nifty total marke... - - - - 1.33
cohesion mk best ideas su... 2.12 2.12 2.17 2.17 2.17
dovetail india fund class... 1.52 1.52 1.52 1.52 1.52
elm park fund limited 1.23 1.23 1.23 1.23 1.23
icici prudential pharma h... 2.82 2.74 - - 2.04
investor education and pr... - - 0.29 - 0.29
pivotal enterprises priva... 2.25 2.25 2.25 2.25 2.25
sapphire intrex limited 1.09 1.09 1.09 1.09 1.09
sbi life insurance co. lt... 1.25 1.61 1.72 1.75 1.73
bandhan small cap fund 1.59 - 1.92 1.45 -
icici prudential elss tax... - - 2.40 2.04 -
investor education and pr... 0.29 0.29 - 0.29 -
viral parikh - - 1.02 1.02 -
bandhan core equity fund - 1.74 - - -
viral amal parikh 1.02 1.02 - - -

Annual Reports

Title Link
Title Link
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit ICRA
Credit ICRA
Credit ICRA
Credit CRISIL
Credit ICRA
TYPE AGENCY Link
TYPE AGENCY Link
Research BP Wealth

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY24
Concall Q4FY23
Concall Q3FY24
Concall Q3FY24
Concall Q2FY24
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q4FY23
Presentation Q4FY21
Presentation Q4FY21
Presentation Q4FY20
Presentation Q3FY24
Presentation Q3FY23
Presentation Q3FY22
Presentation Q2FY24
Presentation Q1FY21

Company News

Shilpa Medicare Stock Price Analysis and Quick Research Report. Is Shilpa Medicare an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Shilpa Medicare. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Shilpa Medicare has a PE ratio of 131.635671355298 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Shilpa Medicare has ROA of 1.0912% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Shilpa Medicare has a Current ratio of 1.6653.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Shilpa Medicare has a ROE of 1.2646%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Shilpa Medicare has a Debt to Equity ratio of 0.0665 which means that the company has low proportion of debt in its capital.

  • Sales growth: Shilpa Medicare has reported revenue growth of 25.0642% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Shilpa Medicare for the current financial year is 7.12393628388058%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Shilpa Medicare is Rs 0 and the yield is 0.1196%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Shilpa Medicare is Rs 6.3558. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Shilpa Medicare in Ticker for free. Also, one can get the intrinsic value of Shilpa Medicare by using Valuation Calculators, which are available with a Finology ONE subscription. 

Shilpa Medicare FAQs

Q1. What is Shilpa Medicare share price today?
Ans: The current share price of Shilpa Medicare is Rs 836.65.

Q2. What is the market capitalisation of Shilpa Medicare?
Ans: Shilpa Medicare has a market capitalisation of Rs 8181.67631782 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Shilpa Medicare?
Ans: The PE ratio of Shilpa Medicare is 131.635671355298 and the P/B ratio of Shilpa Medicare is 3.00654529564512, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Shilpa Medicare share?
Ans: The 52-week high share price of Shilpa Medicare is Rs 1000, and the 52-week low share price of Shilpa Medicare is Rs 555.

Q5. Does Shilpa Medicare pay dividends?
Ans: Currently, Shilpa Medicare pays dividends. Dividend yield of Shilpa Medicare is around 0.1196%.

Q6. What are the face value and book value of Shilpa Medicare shares?
Ans: The face value of Shilpa Medicare shares is Rs 1, while the book value per share of Shilpa Medicare is around Rs 278.2762. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Shilpa Medicare?
Ans: Shilpa Medicare has a total debt of Rs 142.5466 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Shilpa Medicare?
Ans: The ROE of Shilpa Medicare is 1.2646% and ROCE of Shilpa Medicare is 2.36%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Shilpa Medicare a good buy for the long term?
Ans: The Shilpa Medicare long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Shilpa Medicare undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Shilpa Medicare appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Shilpa Medicare’s financials?
Ans: You can review Shilpa Medicare’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Shilpa Medicare
X